2-[(diethylamino)methyl]-4-(4-{3-[(diethylamino)methyl]-4-hydroxyphenyl}hex-3-en-3-yl)phenol

• ChemBase编号: 155040
• 分子式: C28H42N2O2
• 平均质量: 438.64528
• 单一同位素质量: 438.32462859
• SMILES: CC/C(=C(/CC)\c1ccc(c(c1)CN(CC)CC)O)/c1ccc(c(c1)CN(CC)CC)O
• Canonical SMILES: CCN(Cc1cc(ccc1O)/C(=C(/c1ccc(c(c1)CN(CC)CC)O)\CC)/CC)CC
• InChI: InChI=1S/C28H42N2O2/c1-7-25(21-13-15-27(31)23(17-21)19-29(9-3)10-4)26(8-2)22-14-16-28(32)24(18-22)20-30(11-5)12-6/h13-18,31-32H,7-12,19-20H2,1-6H3
• InChIKey: QFNJFVBKASKGEU-UHFFFAOYSA-N

名称和登记号

名称

• IUPAC标准名: 2-[(diethylamino)methyl]-4-(4-{3-[(diethylamino)methyl]-4-hydroxyphenyl}hex-3-en-3-yl)phenol; 2-[(diethylamino)methyl]-4-[(3E)-4-{3-[(diethylamino)methyl]-4-hydroxyphenyl}hex-3-en-3-yl]phenol
• IUPAC传统名: 2-[(diethylamino)methyl]-4-(4-{3-[(diethylamino)methyl]-4-hydroxyphenyl}hex-3-en-3-yl)phenol; 2-[(diethylamino)methyl]-4-[(3E)-4-{3-[(diethylamino)methyl]-4-hydroxyphenyl}hex-3-en-3-yl]phenol
• 别名: (E)-4,4′-(1,2-Diethyl-1,2-ethenediyl)bis[2-[(diethylamino)methyl]-phenol (9CI); 4,4′-(3E)-Hex-3-ene-3,4-diylbis{2-[(diethylamino)methyl]phenol}; G6; NSC 33994; 4,4'-[(1E)-1,2-Diethyl-1,2-ethenediyl]bis[2-[(diethylamino)methyl]phenol; (E)-4,4'-(1,2-Diethyl-1,2-ethenediyl)bis[2-[(diethylamino)methyl]phenol; NSC-33994

登记号

• CAS号: 82058-16-0
• MDL号: MFCD20488055
• PubChem SID: 162249178
• PubChem CID: 5473838

理论计算性质

• Acid pKa: 7.918276
• 质子受体: 4
• 质子供体: 2
• LogD (pH = 5.5): -0.14799179
• LogD (pH = 7.4): 2.647632
• Log P: 4.191591
• 摩尔折射率: 139.3204 cm^3
• 极化性: 53.61732 Å^3
• 极化表面积: 46.94 Å^2
• 可自由旋转的化学键: 12
• 里宾斯基五规则: true

分子性质

理化性质

• 溶解度: DMSO: ≥25 mg/mL
• 外观: white to tan powder

安全信息

• 德国WGK号: 3
• 保存温度: 2-8°C

产品相关信息

• 纯度: ≥98% (HPLC)
• Empirical Formula (Hill Notation): C28H42N2O2

详细说明

Sigma Aldrich - SML0069

Biochem/physiol Actions
NSC 33994 is a potent and specific Jak2 inhibitor that inhibits a notorious mutation, Jak2-V617F, found in large number of myeloproliferative neoplasms.
Potent and specific Jak2 inhibitor effective against Jak2-V617F mutation

Toronto Research Chemicals - N900300

NSC-33994 is novel inhibitor of JAK2 tyrosine kinase (Janus kinase 2 ). Janus kinase 2 (JAK2) plays a crucial role in the pathomechanism of myeloproliferative disorders and hematological malignancies.

参考文献

• Tanner, J., et al.: J. Biol. Chem., 270, 6523 (1995)
• Rane, S., et al.: Oncogene, 19, 5662 (2000, Verma, A., et al.: Cancer Metastasis Rev., 22, 423 (1995)
• Levine, R., et al.: Cancer Cell., 7, 387 (1995)
• Kiss, et al.: Bioorg. Med. Chem. Lett., 19, 3598